Open an account

XWELL

XWEL · NASDAQ

$0.653−$0.0635 (−8.86%)TodayMarket closed ·
Prev close $0.7165

About XWEL

XWELL, Inc. provides global travel health and wellness services. The company is headquartered in New York City, New York and currently employs 175 full-time employees. The company went IPO on 2010-06-18. The firm delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC’s) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others.

Employees
279
Headquarters
New York City, New York
Listed
Jun 18, 2010
Sector
Consumer Discretionary
Industry
Diversified Consumer Services
Website
xwell.com

XWEL key statistics

Market cap
9.20M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
46.88K
Volume
86.09K
Open price
$0.7057
High today
$0.739
Low today
$0.652
52 Week high
$1.82
52 Week low
$0.2551

XWELL (XWEL) at a glance

As of Oct 20, 2026, XWELL (XWEL) shares are priced at $0.653, giving the company a market cap of 9.20M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.652 and $0.739. The current price is 0.2% above the day's low and 11.6% below its high.

Volume so far is 86.09K shares, above the average of 46.88K shares a day.

Over the past year XWELL has ranged from $0.2551 to $1.82, and now sits 26% of the way up that range.

XWELL met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY23 it reported -$2.38 per share against an estimate of -$0.816.

XWEL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 26.3% on average.

  1. Q4 FY21: reported $0.60 per share against an estimate of $1.22
  2. Q1 FY22: reported -$0.80 per share against an estimate of -$1.22
  3. Q2 FY22: reported -$1.60 per share against an estimate of -$2.04
  4. Q3 FY22: reported -$1.60 per share against an estimate of -$1.43
  5. Q4 FY22: reported -$3.00 per share against an estimate of -$1.63
  6. Q1 FY23: reported -$1.40 per share against an estimate of -$2.65
  7. Q2 FY23: reported -$1.40 per share against an estimate of -$1.43
  8. Q3 FY23: reported -$2.38 per share against an estimate of -$0.816

XWEL news

  • 10 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

  • Tanya Rawat

    Trump Sons Back $1 Billion Investment Network Targeting AI, Crypto And Drone Companies Favoured By White House: Report

  • 12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

  • Tanya Rawat

    Trump-Linked Investment Group Backs Airport Wellness Firm Ahead Of 2026 World Cup

  • 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as XWELL

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.